Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03671590 |
|---|---|
| Brief Title: | Study of TG-1701, an Irreversible Bruton's Tyrosine Kinase Inhibitor, in Patients With B-Cell Malignancies |
| First Submitted : | September 12, 2018 |
| First Submitted that Met QC Criteria : | September 12, 2018 |
| First Posted : | September 14, 2018 |
| Last Update Submitted that Met QC Criteria : | March 17, 2023 |
| Last Update Posted : | March 20, 2023 |